Coptisine enhances the sensitivity of chemoresistant breast cancer cells by inhibiting the function and expression of ABC transporters
2024
Coptisine Boosts Chemotherapy Effectiveness in Resistant Breast Cancer Cells
publication
Evidence: moderate
Author Information
Author(s): Eid Safaa Yehia
Primary Institution: Umm Al-Qura University, Makkah, Saudi Arabia
Hypothesis
Combining coptisine with doxorubicin will enhance doxorubicin's efficacy in resistant breast cancer cells.
Conclusion
Coptisine can reverse multidrug resistance in breast cancer cells, enhancing the effectiveness of doxorubicin.
Supporting Evidence
- Coptisine significantly enhances doxorubicin cytotoxicity in resistant breast cancer cell lines.
- The combination of coptisine and doxorubicin shows a synergistic effect.
- Coptisine inhibits the function of ABC transporters, which are responsible for drug resistance.
- Coptisine downregulates the expression of genes associated with multidrug resistance.
Takeaway
Coptisine helps make cancer cells more sensitive to treatment, so they can be killed by chemotherapy drugs better.
Methodology
The study assessed the cytotoxicity of coptisine and its ability to enhance doxorubicin effectiveness using MTT assays, flow cytometry, and RT-PCR.
Limitations
Further in vivo studies are needed to confirm the findings and explore the mechanisms of action.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website